![](https://investorshub.advfn.com/uicon/388659.png?cb=1588544491)
Saturday, March 20, 2021 10:03:27 AM
Moderator - please post for easy access
two formats....compliments of Letruthringout and HDGabor
https://www.investorvillage.com/uploads/87669/files/Motions-24-60.pdf
or....
https://drive.google.com/drive/folders/1mSdBHqmSYoyZLuO8lJYInzZx_IlIGDC5 (17 Documents, see below)
https://drive.google.com/file/d/1JIrr0yPcxow6VlwbNCo6sjUj-gHvSOxv/view (All in 1)
401: INTERVENOR EPADI II’S MOTION TO INTERVENE PURSUANT TO FED. R. CIV. P. 24
ORAL ARGUMENT REQUESTED TELEPHONICALLY OR VIA ZOOM
401-1: INDEX OF EXHIBITS
401-2: Exhibit A: Email from Avi Silberberg, Esq. to Amarin’s CEO, John Thero, requesting that Amarin seek Rule 60 relief, dated November 9, 2020 (Sender and Reciept’s email addresses have been redacted)
401-3: Exhibit B: Yahoo Finance screenshot showing the collapse of Amarin’s stock price in the immediate aftermath of the Judgment, dated March 31, 2020
401-4: Exhibit C: True Excerpts from the Amicus Brief filed by the Aimed Alliance in support of Amarin’s Petition for Certiorari to the United States Supreme Court, dated March 4,2021
401-5: DECLARATION OF MICHAEL S. KASANOFF IN SUPPORT OF EPADI II’S MOTION TO INZERVENE PURSUANT TO FED. R. CIV. P. 24
401-6: CERTIFICATE OF SERVICE
405: INTERVENOR EPADI II’S MOTION TO VACATE JUDGMENT PURSUANT TO FED. R. CIV. P.
ORAL ARGUMENT REQUESTED TELEPHONICALLY OR VIA ZOOM
405-1: INDEX OF EXHIBITS
405-2: Exhibit A: Expert Report prepared by Dr. Gavin E. Jarvis, dated March 12, 2021
405-3: Exhibit B: Dr. Jarvis’s Curriculum Vitae
405-4: Exhibit C: Curfman, G., Bhatt, D.L. & Pencina, M., Federal Judge Invalidates Icosapent Ethyl Patents But Based on a Common Statistical Mistake, Nat. Biotehcnol 38, 939-941(2020)
405-5: Exhibit D: Abstract of the Paper supporting Curfman, G., Bhatt, D.L. & Pencina, M., Federal Judge Invalidates Icosapent Ethyl Patents But Based on a Common Statistical Mistake, Nat. Biotehcnol 38, 939-941(2020)
405-6: Exhibit E: Paper supporting Curfman, G., Bhatt, D.L. & Pencina, M., Federal Judge Invalidates Icosapent Ethyl Patents But Based on a Common Statistical Mistake, Nat. Biotehcnol 38, 939-941(2020)
405-7: Exhibit F: Kurabayashi et. al., Eicosapentaenoic acid effect on hyperlipedema in menopausal Japanese women. Obster Gynecol, 2000;96(4):521-8
405-8: DECLARATION OF MICHAEL S. KASANOFF IN SUPPORT OF EPADI II’S MOTION TO VACATE JUDGMENT PURSUANT TO FED. R. CIV. P. 24
405-9: CERTIFICATE OF SERVICE
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM